Workflow
无锡药明康德新药开发股份有限公司2025年半年度A股权益分派实施公告
Shang Hai Zheng Quan Bao·2025-09-19 19:33

Core Points - The company announced a cash dividend of RMB 0.35000 per share (including tax) for the first half of 2025, totaling RMB 1,033,027,357.60 (including tax) to be distributed among A-share shareholders [2][4] - The distribution plan was approved by the board of directors on July 28, 2025, following authorization from the annual general meeting held on April 29, 2025 [2][3] Distribution Plan - The dividend will be distributed to all A-share shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [3] - The total number of shares for the dividend calculation is 2,951,506,736 shares, with A-shares receiving a total of RMB 865,648,086.10 (including tax) [4] Taxation Details - For individual A-share shareholders, the cash dividend will not be subject to withholding personal income tax at the time of distribution. The actual amount received will be RMB 0.35000 per share [6] - Qualified Foreign Institutional Investors (QFII) will have a 10% corporate income tax withheld, resulting in an actual distribution of RMB 0.31500 per share [7] - Hong Kong investors through the Stock Connect will also face a 10% withholding tax, leading to an effective dividend of RMB 0.31500 per share [8] - Other institutional investors and corporate shareholders will receive the full amount of RMB 0.35000 per share without tax withholding [9]